Mustang Bio Announces $9.28 Million Grant to Fund Phase 1 Trial of CAR T Therapy MB-103 in HER2-Positive Breast Cancer with Brain Metastases

August 13, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search